Jadwiga Kaleta
University of British Columbia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jadwiga Kaleta.
Bioorganic & Medicinal Chemistry Letters | 2003
Nian E. Zhou; Deqi Guo; George Thomas; Andhe V. Narender Reddy; Jadwiga Kaleta; Enrico O. Purisima; Robert Ménard; Ronald G. Micetich; Rajeshwar Singh
A new class of inhibitors for cysteine proteases cathepsin B, L, K and S is described. These inhibitors are based on the beta-lactam ring designed to interact with the nucleophilic thiol of the cysteine in the active site of cysteine proteases. Some 3-acylamino-azetidin-2-one derivatives showed very potent inhibition activities for cathepsins L, K and S at the nanomolar or subnanomolar IC(50) values.
Bioorganic & Medicinal Chemistry Letters | 2002
Nian E. Zhou; Jadwiga Kaleta; Enrico O. Purisima; Robert Ménard; Ronald G. Micetich; Rajeshwar Singh
The synthesis of a new series of 6-acylamino penam derivatives and their inhibition of cysteine proteases cathepsins B, L, K, and S is described. The 6-acylamino-penam sulfone compounds showed excellent cathepsin L, K, and S inhibition activity with IC(50) values in the nanomolar and subnanomolar range.
Bioorganic & Medicinal Chemistry Letters | 1996
Samarendra N. Maiti; David P. Czajkowski; Narender A. V. Reddy; Paul Spevak; Jadwiga Kaleta; Ronald G. Micetich
Abstract Treatment of 3-methyl-3-cephem sulphone with sodium hydride followed by carbon disulphide and alkyl halide provides an entry to 2-(1,3-diothiolan-2-ylidene)-cephem derivatives, which are new potent inhibitors of HSE.
Bioorganic & Medicinal Chemistry Letters | 2002
Nian E. Zhou; Deqi Guo; Jadwiga Kaleta; Enrico O. Purisima; Robert Ménard; Ronald G. Micetich; Rajeshwar Singh
A series of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one compounds was designed and synthesized as a new class of inhibitors for cysteine proteases cathepsins B, L, K, and S. One compound (5S,6S)-6-(N-benzyloxycarbonyl-L-phenylalanyl) amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one showed excellent cathepsin L and K inhibition activity with IC(50) at a low nanomolar range.
Chemistry of Heterocyclic Compounds | 1998
Andhe V. Narender Reddy; Charles Fiakpui; David P. Czajkowski; Jadwiga Kaleta; Ronald G. Micetich; Samarendra N. Maiti
A series of 7α-methoxy-2-[(substituted)methylene]cephem sulfones was synthesized. The compounds with an acetoxy group at the C-3′ position as a leaving group were found to be potent inhibitors of HLE. Selected compounds are also found to be antithrombin agents.
Bioorganic & Medicinal Chemistry Letters | 2017
Natasha Kruglyak; David E. Williams; Henry Chen; Simon Law; Jadwiga Kaleta; Ivan Villanueva; Julian Davies; Raymond J. Andersen; Dieter Brömme
Using a human cathepsin K-targeting inhibitor screen, a new leupeptin analogue, leupeptazin (1), containing an unprecedented piperidinotriazine moiety, was isolated from a liquid culture of soil Streptomyces sp. IS2-4 collected in northern Italy. The structure of leupeptazin was established using HRESIMS as well as 1D and 2D NMR data. The inhibitory activity of the compound towards the collagenase cathepsin K was tested in vitro to reveal moderate activity with an inhibition constant, Ki, of 44μM.
Chemistry of Heterocyclic Compounds | 1998
Andhe V. Narender Reddy; Charles Fiakpui; David P. Czajkowski; Paul Spevak; Jadwiga Kaleta; Ronald G. Micetich; Samarendra N. Maiti
A new series of 2-spiro(2′,2′-diphenylcyclopropane) cephalosporin sulfones was synthesizes as potent human leukocyte elastase inhibitors.
Archive | 2000
Rajeshwar Singh; Andhe V. Narender Reddy; Jadwiga Kaleta; Ronald G. Micetich; Mark Whittaker; Philip Huxley
Archive | 2001
Rajeshwar Singh; Andhe V. Narender Reddy; Nian E. Zhou; Qizhu Ding; George Thomas; Jadwiga Kaleta; Ronald G. Micetich
Archive | 1996
Rajeshwar Singh; Nian E. Zhou; Deqi Guo; Jadwiga Kaleta; Ronald G. Micetich